Soley Therapeutics, Inc. — Form D
Soley Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-22. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-22
- Form: D
- Accession: 0001567619-20-021476
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 32
- Date of first sale: 2020-10-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384030
Issuer
- Name: Soley Therapeutics, Inc.
- CIK: 0001830785
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1 Corporate Drive, South San Francisco, CA, 94080
- Phone: (415) 850-9841
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Ken V Alwyn | Director | South San Francisco, CA |
| Kurosh V Ameri | Director | South San Francisco, CA |
| Yerem V Yeghiazarians | Director | South San Francisco, CA |
| Ken V Alwyn | Executive Officer | South San Francisco, CA |
More